【24h】

Microalbuminuria in Ayurveda

机译:阿育吠陀中的微量白蛋白尿

获取原文
           

摘要

Microalbuminuria is the first stage of Nephropathy; pathology will progress with uncontrolled diabetes and hypertension. It is a complication of diabetes so according to Ayurveda it can be considered under the Santarpanjanya disease, where Kleda (waste) is main causative factor. Albuminuria is nothing but the excess loss of Dhatu Saramsa (finest tissue) due to weakness of Ayanadourbalya (system). The progress of this structural damage gradually leads to a condition in which function of the Srotas (system) is totally get impaired ( Sanga ). This is actually happening in glomerulosclerotic stage of diabetic nephropathy. As function of membrane of Mootradharakala (urinary tract) becomes fully impaired, there is failure in the removal of Kledamsa (waste) and Udaka Bhava s (ions), which leads to their accumulation in the body. This will lead the further progression. As per Charaka quotation, physician need not to name the disease, he should investigate the Sthana (location), Samsthana (cause) and Samutthana (symptoms). So here humble attempt is done to through light on microalbuminuria in Ayurvedic view to understand the disease and plan out the treatment.
机译:微量白蛋白尿是肾病的第一阶段。糖尿病,高血压会导致病理改变。它是糖尿病的并发症,因此,根据阿育吠陀,它可以被认为是在Santarpanjanya病下,其中Kleda(废物)是主要的致病因素。蛋白尿不过是由于Ayanadourbalya(系统)虚弱而造成的Dhatu Saramsa(最优质组织)的过量损失。这种结构性破坏的进展逐渐导致Srotas(系统)的功能完全受损(Sanga)。这实际上发生在糖尿病肾病的肾小球硬化阶段。随着Mootradharakala(尿道)膜功能的完全受损,Kledamsa(废物)和Udaka Bhava(离子)的去除会失败,从而导致它们在体内的积累。这将导致进一步的发展。按照Charaka的说法,医生无需命名疾病,他应该调查Sthana(位置),Samsthana(原因)和Samutthana(症状)。因此,在阿育吠陀的观点中,人们尝试着通过微白蛋白尿来了解疾病并制定治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号